The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 169.80
Bid: 169.60
Ask: 170.00
Change: -1.60 (-0.93%)
Spread: 0.40 (0.236%)
Open: 173.40
High: 173.40
Low: 169.00
Prev. Close: 171.40
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Minority Stake in Filters Division

19 Mar 2019 07:00

RNS Number : 2725T
Essentra plc
19 March 2019
 

ESSENTRA PLC

ACQUISITION OF MINORITY STAKE IN ESSENTRA (MEA) PTE. LTD IN FILTERS DIVISION

Essentra plc ("Essentra" or "the Company") today announces the acquisition of the 49% minority interest in its Filters joint venture, Essentra (MEA) Pte. Ltd, from Aberdeen International FZE (part of the BBM Bommidala group or "BBM") for a cash consideration of £11.6m ("the Transaction"). Essentra (MEA) Pte. Ltd is the holding company of Essentra FZE, which undertakes the Company's Filters activities in Dubai.

Since it was established in 2013, Essentra FZE has served the attractive markets of the Middle East with an increasingly complex range of special filters, which has resulted in strong revenue and profit growth. Accordingly, as the region continues to expand, 100% ownership of Essentra FZE will allow the Company to further invest in additional capacity and to introduce new processes and products in Dubai, and to fully benefit from future potential volume and premiumisation opportunities.

The Transaction is a smaller related party transaction under LR 11.1.10R.

Commenting on today's announcement, Paul Forman, Chief Executive, said:

"In successful partnership with BBM, Essentra FZE has grown considerably over the last six years as the demand for the special filters in the Middle East has increased. As this market trend is expected to be maintained, the acquisition of BBM's minority stake in the joint venture will allow us to expand the Dubai facility into a regional hub and to capture the full potential of this growth region for the benefit of Essentra shareholders."

Enquiries

Essentra plc

Joanna Speed, Investor Relations Director

Lucy Yank, Group Communications Director

Tel: +44 (0)1908 359100

Tulchan Communications LLP

Martin Robinson

Guy Bates

Tel: +44 (0)20 7353 4200

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions. Organised into four divisions from the start of 2018 - reflecting the Company's strategic review - Essentra focuses on the light manufacture and distribution of high volume, enabling components which serve customers in a wide variety of end-markets and geographies.

Essentra Components

Essentra Components is a global market leading manufacturer and distributor of plastic injection moulded, vinyl dip moulded and metal items. Operating in 28 countries worldwide, twelve manufacturing facilities and 29 logistics centres serve more than 85,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics and construction.

Essentra Packaging

Essentra Packaging is one of only two multicontinental suppliers of a full secondary packaging range to the health and personal care sectors, with 22 facilities across four geographic regions. The division's innovative products include cartons, leaflets, self-adhesive labels and printed foils used in blister packs, which help customers to meet the rapidly-changing requirements of these end-markets and can also be combined with Essentra's authentication solutions to help the fight against counterfeiting.

Essentra Filters

Essentra Filters is the only global independent cigarette filter supplier. The seven worldwide locations, plus a dedicated Technology Centre supported by three regional development facilities, provide a flexible infrastructure strategically positioned to serve the tobacco sector. The business supplies a wide range of value-adding high quality innovative filters, packaging solutions to the roll your own segment and analytical laboratory services for ingredient measurement to the industry: Essentra's offering also includes e-cigarette and Heat Not Burn solutions to the rapidly evolving market for Next Generation Products.

Essentra Specialist Components

Essentra Specialist Components comprises the Company's five smaller businesses. These activities largely have strong positions in the markets in which they operate, although they have little overlap with each other or with Essentra's larger three global divisions.

The Extrusion business is a leading custom profile extruder located in The Netherlands which offers a complete design and production service. One of the first companies to extrude plastics, Essentra is now one of Europe's most advanced suppliers of co-extrusion and tri-extrusion to all branches of industry.

The Speciality Tapes business has expertise in coating multiple adhesive systems in numerous technologies, with approximately 1,200 tape products stocked for same-day shipping predominantly for retail point of purchase, appliance and industrial applications.

The Tear Tapes business is globally recognised as the leading manufacturer and supplier of pressure-sensitive tear tapes, which are largely used in the tobacco, food and drink and specialist packaging sectors.

The Industrial Supply business provides a wide range of branded hardware supplies to a broad base of industrial customers, largely located in the US Mid-West.

The Card Solutions business is a leading European provider of ID card printers, systems and accessories to direct and trade customers.

Headquartered in the United Kingdom, Essentra's global network extends to 33 countries and includes c. 8,000 employees, c. 45 principal manufacturing facilities, c. 30 sales & distribution operations and 4 research & development centres. For further information, please visit www.essentraplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQUKSVRKBAOARR
Date   Source Headline
3rd Aug 20217:00 amRNSCompletion of Components Acquisition in China
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSResults for the Half Year Ended 30 June 2021
20th Jul 202112:00 pmRNSInvitation to HY 2021 Results Presentation
7th Jul 20217:00 amRNSHY 2021 Pre-Close Trading Update
1st Jul 20217:50 amRNSChange of Registered Office
1st Jul 20217:48 amRNSTotal Voting Rights
28th Jun 20214:02 pmRNSDirectorate Change
25th Jun 20215:01 pmRNSAppointment of a Non-Executive Director
2nd Jun 20218:25 amRNSTotal Voting Rights
28th May 20213:38 pmRNSHolding(s) in Company
20th May 202112:30 pmRNSResult of AGM
20th May 20217:00 amRNSAGM 2021 Trading Update
18th May 20217:25 amRNSDirector Declaration
13th May 20217:00 amRNSComponents Acquisition in China
4th May 202111:21 amRNSTotal Voting Rights
21st Apr 20217:00 amRNSHolding(s) in Company
16th Apr 20217:00 amRNS1st Quarter Results
9th Apr 202111:00 amRNSForthcoming Q1 2021 Trading Update
1st Apr 20214:17 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20213:59 pmRNSDirector/PDMR Shareholding
1st Apr 20213:56 pmRNSDirector/PDMR Shareholding
1st Apr 20213:54 pmRNSDirector/PDMR Shareholding
1st Apr 202110:10 amRNSTotal Voting Rights
30th Mar 20212:53 pmRNSDirector/PDMR Shareholding
30th Mar 202112:24 pmRNSDirector/PDMR Shareholding
10th Mar 20213:52 pmRNSDirector/PDMR Shareholding
5th Mar 20217:05 amRNSBoard Changes
5th Mar 20217:00 amRNSResults for the Full Year Ended 31 December 2020
2nd Mar 202111:41 amRNSHolding(s) in Company
1st Mar 20218:30 amRNSTotal Voting Rights
26th Feb 202112:00 pmRNSInvitation to Full Year 2020 Results Presentation
24th Feb 20214:03 pmRNSHolding(s) in Company
2nd Feb 20211:00 pmRNSDate for FY 2020 Results Announcement
1st Feb 20218:53 amRNSTotal Voting Rights
27th Jan 20217:12 amRNSDirector Declaration
8th Jan 20217:00 amRNSFY20 Pre-Close Trading Statement
4th Jan 20217:00 amRNSTotal Voting Rights
24th Dec 20207:00 amRNSHolding(s) in Company
4th Dec 202011:58 amRNSDirector Declaration
1st Dec 20208:11 amRNSTotal Voting Rights
27th Nov 20204:40 pmRNSSecond Price Monitoring Extn
27th Nov 20204:35 pmRNSPrice Monitoring Extension
16th Nov 202011:42 amRNSHolding(s) in Company
2nd Nov 202011:08 amRNSTotal Voting Rights
29th Oct 20204:41 pmRNSDirector/PDMR Shareholding
29th Oct 20204:37 pmRNSDirector/PDMR Shareholding
23rd Oct 20207:00 amRNSQ3 2020 Trading Update
14th Oct 202010:26 amRNSDirector/PDMR Shareholding
7th Oct 20207:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.